Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis. [electronic resource]
Producer: 20100604Description: 688-99 p. digitalISSN:- 1463-1326
- 11-beta-Hydroxysteroid Dehydrogenase Type 1 -- antagonists & inhibitors
- Adipose Tissue -- drug effects
- Animals
- Atherosclerosis -- complications
- Blood Glucose -- analysis
- Body Composition -- drug effects
- Body Weight -- drug effects
- Cholesterol -- blood
- Diabetes Mellitus, Type 2 -- complications
- Disease Models, Animal
- Dyslipidemias -- complications
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypoglycemic Agents -- therapeutic use
- Insulin -- blood
- Male
- Metabolic Syndrome -- complications
- Mice
- Mice, Knockout
- Rosiglitazone
- Simvastatin -- pharmacology
- Thiazolidinediones -- therapeutic use
- Triglycerides -- blood
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.